NeuroThera Labs Inc.
Neurothera Labs Inc. operates a clinical-stage pharmaceutical company. The company engaged in the following drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome, for the treatment of Alzheimer's disease and agitation; and SCI- 210 for the treatment of ASD and status epilepticus. Neurothera Labs Inc. was formerly known as Miza III Ventu… Read more
Market Cap & Net Worth: NeuroThera Labs Inc. (NTLX)
NeuroThera Labs Inc. (V:NTLX) has a market capitalization of $9.11 Million (CA$13.08 Million) as of March 18, 2026. Listed on the V stock exchange, this Canada-based company holds position #48109 globally and #764 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NeuroThera Labs Inc.'s stock price CA$0.16 by its total outstanding shares 84400000 (84.40 Million).
NeuroThera Labs Inc. Market Cap History: 2025 to 2026
NeuroThera Labs Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $9.99 Million to $9.11 Million (0.00% CAGR).
NeuroThera Labs Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NeuroThera Labs Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NTLX by Market Capitalization
Companies near NeuroThera Labs Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to NeuroThera Labs Inc. by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
NeuroThera Labs Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, NeuroThera Labs Inc.'s market cap moved from $9.99 Million to $ 9.11 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$9.11 Million | -8.82% |
| 2025 | CA$9.99 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NeuroThera Labs Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.11 Million USD |
| MoneyControl | $9.11 Million USD |
| MarketWatch | $9.11 Million USD |
| marketcap.company | $9.11 Million USD |
| Reuters | $9.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.